Clinical Trial Update: PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT) [Phase 4]

View source ↗

Summary

Phase IV trial update for a ceftriaxone-sulbactam injectable combination in pediatric respiratory and urinary tract infections. Status: completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection
• Urinary Tract Infection in Children

Drugs mentioned

• Ceftriaxone Sodium and Sulbactam Sodium for Injection (ceftriaxone-sulbactam)

Snippet

Sponsor: Xiangbei Welman Pharmaceutical Co., Ltd | Conditions: Respiratory Tract Infections, Urinary Tract Infections in Children | Phase 4 | Status: COMPLETED